DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Zalutumumab is an investigational drug.
There have been 9 clinical trials for Zalutumumab. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2006.
The most common disease conditions in clinical trials are Head and Neck Neoplasms, Carcinoma, Squamous Cell, and Neoplasms, Squamous Cell. The leading clinical trial sponsors are Genmab, Danish Head and Neck Cancer Group, and [disabled in preview].
Recent Clinical Trials for Zalutumumab
|Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy||Genmab||Phase 1/Phase 2|
|Zalutumumab With or Without Irinotecan Chemotherapy in Cetuximab-Refractory Colorectal Cancer||Genmab||Phase 1/Phase 2|
|Zalutumumab in Non-curable Patients With SCCHN||Genmab||Phase 2|